Translational Neuroscience Strategy

About Translational Neuroscience Strategy

Translational Neuroscience Strategy provides advisory support to biotechnology, pharmaceutical, neurotechnology, and life science companies developing innovative neuroscience therapeutics, technologies, and research platforms. Led by Jonathan Nassi, PhD, with experience spanning translational neuroscience, neurotechnology development, preclinical research, and industry collaboration. Advisory areas include translational and preclinical strategy, model and assay development, biomarker and endpoint strategy, large-animal/NHP translation, pharmaceutical applications, and scientific partnership strategy. Available for advisory, fractional leadership, and project-based engagements.